No Data
Novartis Says 330 Jobs Hit as It Closes MorphoSys Sites
European Stocks That Trade Cheaper Than U.S. Peers
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Sanofi: Kress Was the CEO of MorphoSys From 2019 Until It Was Acquired by Novartis in 2024
Novartis will close MorphoSys's factories in Germany and the USA.
According to Reuters on December 19, the Swiss pharmaceutical group Novartis announced on Thursday that it will close the German Biotechnology company MorphoSys's factories in Germany and the USA, acquired earlier this year, affecting approximately 330 positions. A company spokesperson stated that the plan is to exit the factories in Munich and Boston by the end of 2025 and to consolidate all portfolio activities into Novartis.
Market Chatter: Novartis to Close MorphoSys Sites, Affecting 330 Jobs